2 companies

Showing 1–2 of 2 companies

SAB Biotherapeutics

Clinical-stage biopharmaceutical company developing fully human IgG immunotherapies for autoimmune diseases, led by SAB-142 for Type 1 Diabetes.

1 open job

MoonLake Immunotherapeutics

Clinical-stage biopharmaceutical company developing Nanobody-based immunotherapies for inflammatory skin and joint diseases, including hidradenitis suppurativa.

2 companies

SAB Biotherapeutics

MoonLake Immunotherapeutics

Browse by market